Literature DB >> 22538131

Blood glucose meters and accessibility to blind and visually impaired people.

Darren M Burton1, Matthew G Enigk, John W Lilly.   

Abstract

In 2007, five blood glucose meters (BGMs) were introduced with integrated speech output necessary for use by persons with vision loss. One of those five meters had fully integrated speech output, allowing a person with vision loss independence in accessing all features and functions of the meter. In comparison, 13 BGMs with integrated speech output were available in 2011. Accessibility attributes of these 11 meters were tabulated and product design features examined. All 13 meters were found to be usable by persons with vision loss to obtain a blood glucose measurement. However, only 4 of them featured the fully integrated speech output necessary for a person with vision loss to access all features and functions independently.
© 2012 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22538131      PMCID: PMC3380763          DOI: 10.1177/193229681200600205

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  1 in total

1.  Blood glucose meters that are accessible to blind and visually impaired persons.

Authors:  Mark M Uslan; Darren M Burton; Charles W Clements
Journal:  J Diabetes Sci Technol       Date:  2008-03
  1 in total
  3 in total

1.  Accessibility attributes of blood glucose meter and home blood pressure monitor displays for visually impaired persons.

Authors:  Morgan V Blubaugh; Mark M Uslan
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

Review 2.  Usability of Medical Devices for Patients With Diabetes Who Are Visually Impaired or Blind.

Authors:  Lutz Heinemann; Diana Drossel; Guido Freckmann; Bernhard Kulzer
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

3.  Continuous Glucose Monitor with Siri Integration Improves Glycemic Control in Legally Blind Patients with Diabetes.

Authors:  H Kaan Akturk; Janet K Snell-Bergeon; Viral N Shah
Journal:  Diabetes Technol Ther       Date:  2020-07-30       Impact factor: 6.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.